TrialThe Journal of clinical investigation2021

B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin.

Emily S Ford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.